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	 A	series	of	new	imidazolidineiminothiones	(2‐4)	and	bis‐imidazolidineiminothiones	(5)	were
synthesized	through	the	cycloaddition	reaction	of	N‐arylcyanothioformamides	(1)	with	some
electrophilic	 reagents.	 Structure	 of	 imidazolidineiminothione	 derivatives	 were	 established
based	 on	 spectroscopic	 IR,	 1H	 NMR,	 13C	 NMR,	 MS	 and	 elemental	 analyses	 data.	 These
compounds	 were	 screened	 for	 their	 antibacterial	 and	 antifungal	 activities.	 Among	 the
synthesized	 compounds,	 imidazolidineiminothione	 derivative	 3a	 showed	 about	 25%	 less
potent	 effect	 than	 Ampicillin	 against	 S.	 epidermidis	 and	 B.	 subtilis	 (MIC,	 0.49	 μg/mL)	 and
about	50	%	less	potent	effect	than	Amphotericin	B	against	A.	clavatus	and	G.	Candidum.	Bis‐
imidazolidineiminothione	derivative	5a	was	equipotent	 to	 the	Gentamycin	 in	 inhibiting	the
growth	 of	 N.	 gonorrhoeae	 (MIC,	 0.49	 μg/mL),	 and	 displayed	 50%	 less	 active	 than
Amphotericin	B	against	A.	clavatus.	
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1.	Introduction	
	
Infectious	diseases	caused	by	bacteria	and	fungi	remain	a	
major	worldwide	health	problem	due	to	rapid	development	of	
resistance	 to	 the	 existing	 antibacterial	 and	 antifungal	 drugs.	
So,	 the	 medical	 community	 faces	 a	 serious	 problem	 against	
infections	 caused	 by	 the	 pathogenic	 microbes	 and	 needs	
effective	 therapies	 and	search	 for	novel	 antimicrobial	 agents.	
The	quest	for	new	and	effective	antimicrobial	agents,	resistant	
to	 the	 mechanisms	 of	 defense	 of	 these	 bacteria,	 is	 of	 para‐
mount	importance	[1‐3].	
Imidazoles	and	their	fused	derivatives	are	key	components	
of	 great	 many	 bioactive	 compounds	 of	 both	 natural	 and	
synthetic	origin	[4]	such	as	histidine,	purines	and	biotin.	Anti‐
microbial	 activity	 was	 stated	 among	 derivatives	 possessing	
aromatic	substituents	at	the	imidazole	nitrogen	e.g.	N‐acyl	and	
5‐arylidene	 derivatives	 of	 hydantoin	 and	 4‐thiohydantoin	
[5,6].	Moreover,	previous	reports	demonstrated	that	synthetic	
imidazoles	act	either	as	inhibitors	of	α‐adrenoceptor	mediated	
events	 in	 platelets	 [7]	 or	 inducers	 of	 platelets	 activation	 [8].	
Imidazolidineiminothiones	 and	 the	 various	 heterocycles	
derived	from	them	were	shown	to	exhibit	an	interesting	and	a	
wide	 range	 of	 pharmacological	 effects	 including	 antitumor,	
antiviral,	antimicrobial	and	antifungal	strains	[9‐15].	N‐Substi‐
tuted	 cyanothioformamides	were	 used	 as	 a	 key	 intermediate	
for	a	number	of	 interesting	heterocyclic	ring	closures	such	as	
imidazole	 [16],	 oxazole	 [17],	 and	 thiazole	 [18,19].	 In	 parti‐
cular,	 their	 reactions	 with	 isocyanates	 [16]	 and	 isothiocya‐
nates	[17]	give	1,3‐disubstituted	imidazolidine	systems.	
In	 view	 of	 the	 above‐mentioned	 findings,	 and	 as	 a	
continuation	 of	 our	 effort	 to	 identify	 new	 candidates	 [9‐15],	
which	are	crucial	 in	designing	new,	potent,	selective,	and	less	
toxic	antimicrobial	agents,	 its	report	herein	the	synthesis	and	
antimicrobial	 evaluation	 of	 some	 novel	 imidazolidineimino	
thione.	 The	 target	 compounds	 were	 rationalized	 so	 as	 to	
comprise	 some	 pharmacophores	 that	 are	 believed	 to	 be	
responsible	 for	 the	 biological	 activity	 of	 some	 relevant	
chemotherapeutic	 such	 as	 the	 carbonyl,	 thiocarbonyl,	 imino	
and	 cyano	 groups	 functionalities.	 The	 substitution	 pattern	 of	
the	 imidazolidineiminothione	 ring	 was	 carefully	 selected	 in	
order	 to	 confer	 different	 electronic	 environment	 to	 the	
molecules.		
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Scheme	1
	
	
2.	Experimental		
	
All	 the	 melting	 points	 are	 uncorrected.	 IR	 (KBr)	 spectra	
were	measured	on	Shimadzu	440	spectrometer.	 1H	NMR	and	
13C	NMR	spectra	were	obtained	in	DMSO‐d6	on	a	Varian	Gemini	
300	 MHz	 spectrometer	 using	 TMS	 as	 internal	 standard.	 The	
chemical	 shifts	 are	 reported	 as	 δ	 ppm	 units	 at	 the	 Micro‐
analytical	 Center	 in	 National	 Research	 Center,	 Egypt.	 Mass	
spectra	 were	 obtained	 on	 GCMS/QP	 1000	 Ex	 mass	 spectro‐
meter	at	70	eV	at	National	Research	Center,	Egypt.	Elemental	
analyses	 were	 carried	 out	 at	 the	 Department	 of	 Chemistry,	
Faculty	 of	 Science,	 Cairo	 University,	 Egypt.	 Microbiology	
screening	 was	 carried	 out	 in	 the	 Regional	 Center	 for	
Microbiology	 and	 Biotechnology	 (RCMB),	 Antimicrobial	 unit	
test	organisms,	Al‐Azhr	University,	Cairo,	Egypt.	
	
2.1.	Chemistry		
	
2.1.1.	Synthesis	of	2‐(aryldiazenyl)‐2‐(1‐(4‐fluorophenyl)‐4‐
imino‐5‐thioxoimidazolidin‐2‐ylidene)acetonitriles	(2a‐c)	
	
A	 mixture	 of	 cyanothioformamide	 (1a)	 (0.01	 mol),	
arylhydrazonomalononitriles	 (0.01	mol)	 and	 of	 triethylamine	
(3	drops)	in	absolute	ethanol	was	heated	under	reflux	for	4	h.	
left	to	cool.	The	solid	product	was	collected	and	recrystallized	
from	dioxane	to	give	compounds	2a‐c	(Scheme	1).	
2‐((3,4‐Dichlorophenyl)diazenyl)‐2‐(1‐(4‐fluorophenyl)‐4‐
imino‐5‐thioxoimid‐azolidin‐2‐ylidene)acetonitrile	 (2a):	 Color:	
Gray.	 Yield:	 73	 %.	 M.p.:	 258‐260	 °C.	 IR	 (KBr,	 ν,	 cm‐1):	 3410	
(NH),	 2201	 (C≡N),	 1671	 (C=N),	 1574	 (N=N),	 1186	 (C=S).	 1H	
NMR	 (300	MHz,	 DMSO‐d6,	 δ,	 ppm):	 6.43‐7.64	 (m,	 7H,	 Ar‐H),	
8.87	 (br,	 1H,	 NH;	 exchangeable	 with	 D2O),	 9.81	 (br,	 1H,	 NH,	
exchangeable	with	D2O).	MS	(EI,	m/z	(%)):	418	(M+;	24.7),	419	
(M+1;	28.2),	245	(12.6),	174	(18.4),	159	(19.2),	145	(100),	109	
(56.8),	 95	 (67.5),	 75	 (36.4).	 Anal.	 calcd.	 for	 C17H9Cl2FN6S:	 C,	
48.70;	H,	2.16;	N,	20.05.	Found:	C,	48.48;	H,	2.02;	N,	20.18%.	
2‐(1‐(4‐Fluorophenyl)‐4‐imino‐5‐thioxoimidazolidin‐2‐ylide	
ne)‐2‐(p‐tolyldiazenyl)acetonitrile	 (2b):	 Color:	 Gray.	 Yield:	 72	
%.	M.p.:	190‐191	°C.	IR	(KBr,	ν,	cm‐1):	3401	(NH),	2213	(C≡N),	
1671	 (C=N),	 1584	 (N=N),	 1182	 (C=S).	 1H	 NMR	 (300	 MHz,	
DMSO‐d6,	 δ,	ppm):	2.26	 (s,	3H,	CH3),	6.73‐7.52	(m,	8H,	Ar‐H),	
8.63	 (br,	 1H,	 NH;	 exchangeable	 with	 D2O),	 9.56	 (br,	 1H,	 NH,	
exchangeable	with	D2O).	13C	NMR	(75	MHz,	DMSO‐d6,	δ,	ppm):	
21.4	(CH3),	105.1,	113.3,	116.7,	116.9,	122.5	(2C),	129.9	(2C),	
130.7,	 130.8,	 135.4,	 141.5,	 150.8,	 160.5,	 161.9,	 164.6,	 188.2	
(C=S).	MS	 (EI,	m/z	 (%)):	 364	 (M+;	 54.2	%),	 365	 (M+1;	 19.2),	
264	 (22.4),	 119	 (21.2),	 9	 (100),	 65	 (65.8).	 Anal.	 calcd.	 for	
C18H13FN6S:	 C,	 59.33;	 H,	 3.60;	 N,	 23.06.	 Found:	 C,	 59.46;	 H,	
3.81;	N,	23.42%.	
2‐(1‐(4‐Fluorophenyl)‐4‐imino‐5‐thioxoimidazolidin‐2‐ylide	
ne)‐2‐(4‐methoxy‐phenyldiazenyl)acetonitrile	 (2c):	 Color:	
White.	 Yield:	 71%.	 M.p.:	 260‐262	 °C.	 IR	 (KBr,	 ν,	 cm‐1):	 3401	
(NH),	 2214	 (CN),	 1666	 (C=N),	 1585	 (N=N),	 1137	 (C=S).	 1H	
NMR	 (300	MHz,	 DMSO‐d6,	 δ,	 ppm):	 3.86	 (s,	 3H,	 OCH3),	 6.81‐
7.53	(m,	8H,	Ar‐H),	8.52	(br,	1H,	NH,	exchangeable	with	D2O),	
9.45	 (br,	1H,	NH,	exchangeable	with	D2O).	 13C	NMR	(75	MHz,	
DMSO‐d6,	δ,	ppm):	56.1	(OCH3),	105.2,	114.6,	116.7,	116.9	(2C),	
122.5	(2C),	124.5	(2C),	130.3	(2C),	130.7,	147.2,	160.4,	161.9,	
163.6,	 187.8	 (C=S).	MS	 (EI,	m/z	 (%)):	 380	 (M+;	 77.2	%),	 380	
(M+1;	22.2),	235	(22.4),	107	(100),	93	(44.8)	77	(15.2).	Anal.	
calcd.	 for	 C18H13FN6OS:	 C,	 56.83;	 H,	 3.44;	 N,	 22.09.	 Found:	 C,	
57.11;	H,	3.28;	N,	21.97	%.	
	
2.1.2.	Synthesis	of	1‐butyl‐5‐imino‐3‐(aryl)‐4‐thioxo	
imidazolidin‐2‐ones	(3a‐c)	
	
To	a	solution	of	compound	1a,b	and	d	(0.01	mol)	in	ether	
(20	mL),	n‐butylisocyanate	 (0.01	mol)	and	 triethylamine	 (0.5	
mL)	 were	 added;	 the	 reaction	 mixture	 was	 stirred	 at	 room	
temperature	for	2	hr.	The	obtained	products	were	crystallized	
from	absolute	ethanol	to	form	compounds	3a‐c	(Scheme	2).		
1‐Butyl‐3‐(4‐fluorophenyl)‐5‐imino‐4‐thioxoimidazolidin‐2‐
one	(3a):	Color:	White.	Yield:	83	%.	M.p.:	80‐82	°C.	IR	(KBr,	ν,	
cm‐1):	 3250	 (NH),	 2960	 (CH‐aliph),	 1766	 (C=O),	 1660	 (C=N).	
1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	0.91	(t,	3H,	J	=	11.5	Hz,	
CH3),	 1.33	 (h,	 2H,	 J	 =	 12.0	Hz,	 CH2),	 1.67	 (p,	 2H,	 J	 =	 12.0	Hz,	
CH2),	 3.68	 (t,	 2H,	 J	 =	 11.5	 Hz,	 CH2),	 7.35‐7.42	 (m,	 2H,	 Ar‐H),	
7.54‐7.58	 (m,	2H,	Ar‐H),	9.47	 (br,	 1H,	NH,	 exchangeable	with	
D2O).	Anal.	calcd.	 for	C13H14FN3OS:	C,	55.90;	H,	5.05;	N,	15.04.	
Found:	C,	56.14;	H,	4.89;	N,	15.11%.	
1‐Butyl‐5‐imino‐4‐thioxo‐3‐p‐tolylimidazolidin‐2‐one	 (3b):	
Color:	 Yellow.	 Yield:	 79	%.	 M.p.:	 95‐97	 °C.	 IR	 (KBr,	 ν,	 cm‐1):	
3250	(NH),	2951	(CH‐aliph),	1765	(C=O),	1660	(C=N).	1H	NMR	
(300	MHz,	DMSO‐d6,	δ,	ppm):	0.95	(t,	3H,	J	=	11.5	Hz,	CH3),	1.32	
(h,	2H,	J	=	11.5	Hz,	CH2),	1.67	(p,	2H,	J	=	12.0	Hz,	CH2),	2.36	(s,	
3H,	CH3),	3.67	(t,	2H,	J	=	12.0	Hz,	CH2),	7.32	(s,	4H,	Ar‐H),	9.44	
(br,	1H,	NH;	exchangeable	with	D2O).		
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13C	 NMR	 (75	 MHz,	 DMSO‐d6,	 δ,	 ppm):	 13.5	 (CH3),	 19.3	
(CH2),	20.7	 (CH3),	20.8	 (CH2),	29.0	 (CH2),	127.2,	127.3,	129.4,	
129.6,	 130.6,	 138.9,	 153.8	 (C=N),	 154.6	 (C=O),	 183.1	 (C=S).	
Anal.	calcd.	for	C14H17N3OS:	C,	61.06;	H,	6.22;	N,	15.26.	Found:	
C,	61.32;	H,	6.42;	N,	15.52%.		
1‐Butyl‐5‐imino‐3‐(4‐methoxyphenyl)‐4‐thioxoimidazolidin‐
2‐one	(3c):	Color:	Gray.	Yield:	80	%.	M.p.:	110‐112	°C.	IR	(KBr,	
ν,	cm‐1):	3242	(NH),	2951	(CH‐aliph),	1763	(C=O),	1656	(C=N).	
1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	0.91	(t,	3H,	J	=	11.5	Hz,	
CH3),	1.3	(h,	2H,	J	=	11.5	Hz,	CH2),	1.69	(p,	2H,	J	=	11.5	Hz,	CH2),	
3.69	(t,	2H,	J	=	12.0	Hz,	CH2),	3.81	(s,	3H,	OCH3),	7.05	(d,	2H,	J	=	
8.5	Hz,	Ar‐H),	7.36	(d,	2H,	 J	=	8.5	Hz,	Ar‐H),	9.42	(br,	1H,	NH;	
exchangeable	with	D2O).	Anal.	calcd.	for	C14H17N3O2S:	C,	57.71;	
H,	5.88;	N,	14.42.	Found:	C,	57.62;	H,	5.74;	N,	14.23%.	
	
2.1.3.	Synthesis	of	1‐(aryl)‐4‐imino‐3‐(3‐isocyanato‐4‐
methylphenyl)‐5‐thioxoimid‐azolidin‐2‐ones	(4a‐d)	
	
A	 mixture	 of	 cyanothioformamides	 1b‐e	 (0.01	 mol)	 in	
ether	 (20	 mL),	 toluenediisocyanate	 (0.01	 mol)	 and	
triethylamine	(0.5	mL)	were	added,	the	reaction	mixture	was	
stirred	at	room	temperature	for	0.5	hr.	The	obtained	products	
were	 crystallized	 from	 proper	 solvent	 to	 afford	 5‐imino‐4‐
thioxo‐2‐imidazolidinones	4a‐d	(Scheme	2).		
4‐Imino‐3‐(3‐isocyanato‐4‐methylphenyl)‐5‐thioxo‐1‐p‐tolyl	
imidazolidin‐2‐one	 (4a):	 Color:	 Gray.	 Yield:	 77	 %.	 M.p.:	 217‐
219	 °C.	 IR	 (KBr,	 ν,	 cm‐1):	 3238	 (NH),	 2971	 (CH‐aliph),	 2272	
(NCO),	1775	(C=O),	1667	(C=N).	1H	NMR	(300	MHz,	DMSO‐d6,	
δ,	ppm):	1.82	(s,	3H,	CH3),	2.33	(s,	3H,	CH3),	7.05‐7.53	(m,	7H,	
Ar‐H),	 9.52	 (s,	 1H,	 NH,	 exchangeable	with	 D2O).	MS	 (EI,	m/z	
(%)):	 350	 (M+,	 14.2),	 351	 (M+1,	 3.5),	 149	 (35.9),	 148	 (100),	
122	 (13.2),	 107	 (12.7),	 92	 (10.8),	 77	 (27.4).	 Anal.	 calcd.	 for	
C18H14N4O2S:	 C,	 61.70;	 H,	 4.03;	 N,	 15.99.	 Found:	 C,	 61.42;	 H,	
4.12;	N,	15.77%.	
4‐Imino‐3‐(3‐isocyanato‐4‐methylphenyl)‐1‐(3‐methoxy	
phenyl)‐5‐thioxoimidazolidin‐2‐one	(4b):	Color:	Beige.	Yield:	81	
%.	M.p.:	233‐235	 °C.	 IR	 (KBr,	 ν,	 cm‐1):	 3343	 (NH),	2968	 (CH‐
aliph),	 2270	 (NCO),	 1779	 (C=O),	 1665	 (C=N).	 1H	 NMR	 (300	
MHz,	DMSO‐d6,	δ,	ppm):	2.35	(s,	3H,	CH3),	3.79	(s,	3H,	OCH3),	
7.07‐7.97	 (m,	 7H,	 Ar‐H),	 9.60	 (s,	 1H,	NH,	D2O	 exchanagable).	
Anal.	calcd.	for	C18H14N4O3S:	C,	59.01;	H,	3.85;	N,	15.29.	Found:	
C,	59.21;	H,	3.77;	N,	15.42%.	
4‐Imino‐3‐(3‐isocyanato‐4‐methylphenyl)‐1‐(4‐methoxy	
phenyl)‐5‐thioxoimidazolidin‐2‐one	 (4c):	Color:	Gray.	Yield:	78	
%.	M.p.:	 248‐250	 °C.	 IR	 (KBr,	 ν,	 cm‐1):	 3352	 (NH),	2924	 (CH‐
aliph),	 2267	 (NCO),	 1778	 (C=O),	 1666	 (C=N).	 1H	 NMR	 (300	
MHz,	DMSO‐d6,	δ,	ppm):	2.34	(s,	3H,	CH3),	3.83	(s,	3H,	OCH3),	
7.08‐7.52	 (m,	 7H,	 Ar‐H),	 9.70	 (s,	 1H,	 NH,	 exchangeable	 with	
D2O).	Anal.	 calcd.	 for	C18H14N4O3S:	C,	59.01;	H,	3.85;	N,	15.29.	
Found:	C,	58.85;	H,	3.72;	N,	15.33%.	
1‐(3‐Ethoxyphenyl)‐4‐imino‐3‐(3‐isocyanato‐4‐methylphen	
yl)‐5‐thioxoimidazolidin‐2‐one	 (4d):	 Color:	Beige.	 Yield:	 79	%.	
M.p.:	 216‐218	 °C.	 IR	 (KBr,	 ν,	 cm‐1):	 3346	 (NH),	 2978	 (CH‐
aliph),	 2271	 (NCO),	 1779	 (C=O),	 1665	 (C=N).	 1H	 NMR	 (300	
MHz,	DMSO‐d6,	 δ,	 ppm):	1.34	 (t,	 3H,	 J	 =	6.9	Hz,	CH3),	2.35	 (s,	
3H,	CH3),	4.05	(q,	2H,	J	=	6.9	Hz,	CH2),	7.07‐7.97	(m,	7H,	Ar‐H),	
9.60	 (s,	 1H,	 NH,	 exchangeable	 with	 D2O).	 Anal.	 calcd.	 for	
C19H16N4O3S:	 C,	 59.99;	 H,	 4.24;	 N,	 14.73.	 Found:	 C,	 60.15;	 H,	
4.13;	N,	14.59%.	
	
2.1.4.	Synthesis	of	3,3'‐(4‐methyl‐1,3‐phenylene)bis(1‐
(aryl)‐5‐imino‐4‐thioxoimid‐azolidin‐2‐ones	(5a‐d)	
	
A	 mixture	 of	 cyanothioformamides	 1b‐e	 (0.02	 mol)	 in	
ether	 (20	 mL),	 toluenediisocyanate	 (0.01	 mol)	 and	 triethy‐
lamine	(0.5	mL)	were	added,	the	reaction	mixture	was	stirred	
at	 room	 temperature	 for	 1	 hr.	 The	 obtained	 products	 were	
crystallized	 from	 ethanol	 to	 afford	 bis‐imidazolidineimino	
thiones	5a‐d	(Scheme	2).	
3,3'‐(4‐Methyl‐1,3‐phenylene)bis(4‐imino‐5‐thioxo‐1‐p‐tolyl	
imidazolidin‐2‐one)	 (5a):	Color:	Beige.	Yield:	83	%.	M.p.:	165‐
167	 °C.	 IR	 (KBr,	 ν,	 cm‐1):	 3304	 (br,	 2NH),	 2922	 (CH‐aliph),	
1779	(br,	2C=O),	1665	(br,	2C=NH),	1219	(br,	2C=S).	1H	NMR	
(300	MHz,	DMSO‐d6,	 δ,	 ppm):	 2.28	 (s,	 6H,	2CH3),	 2.39	 (s,	 3H,	
CH3),	7.08‐8.47	(m,	11H,	Ar‐H),	9.58	(s,	1H,	NH,	exchangeable	
with	D2O),	9.59	(s,	1H,	NH,	D2O	exchangeable).	Anal.	calcd.	for	
C27H22N6O2S2:	 C,	 61.58;	H,	 4.21;	N,	 15.96.	 Found:	 C,	 61.44;	H,	
4.15;	N,	15.77%.	
3,3'‐(4‐Methyl‐1,3‐phenylene)bis(4‐imino‐1‐(3‐methoxy	
phenyl)‐5‐thioxoimidazolidin‐2‐one)	(5b):	Color:	Gray.	Yield:	85	
%.	M.p.:	 139‐141°C.	 IR	 (KBr,	 ν,	 cm‐1):	 3340	 (NH),	 2923	 (CH‐
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aliph),	 1779	 (br,	 C=O),	 1664	 (br,	 C=NH),	 1223	 (br,	 C=S).	 1H	
NMR	 (300	MHz,	DMSO‐d6,	 δ,	ppm):	2.36	 (s,	 3H,	CH3),	3.80	 (s,	
6H,	 2OCH3),	 7.09‐7.49	 (m,	 11H,	 Ar‐H),	 9.61	 (s,	 1H,	 NH,	
exchangeable	 with	 D2O),	 9.71	 (s,	 1H,	 NH,	 exchangeable	 with	
D2O).	Anal.	calcd.	for	C27H22N6O4S2:	C,	58.05;	H,	3.97;	N,	15.04.	
Found:	C,	58.14;	H,	3.88;	N,	15.17%.	
3,3'‐(4‐Methyl‐1,3‐phenylene)bis(4‐imino‐1‐(4‐methoxyphe	
nyl)‐5‐thioxoimidazolidin‐2‐one)	(5c):	Color:	Gray.	Yield:	84	%.	
M.p.:	248‐250	°C.	IR	(KBr,	ν,	cm‐1):	3232	(br,	2NH),	2927	(CH‐
aliph),	1778	(br,	2C=O),	1666	(br,	2C=NH),	1167	(br,	2C=S).	1H	
NMR	 (300	MHz,	DMSO‐d6,	 δ,	ppm):	2.34	 (s,	 3H,	CH3),	3.83	 (s,	
6H,	 2OCH3),	 7.11‐7.78	 (m,	 11H,	 Ar‐H),	 9.66	 (s,	 1H,	 NH,	
exchangeable	 with	 D2O),	 9.70	 (s,	 1H,	 NH,	 exchangeable	 with	
D2O).	 13C	 NMR	 (75	MHz,	 DMSO‐d6,	 δ,	 ppm):	 17.9	 (CH3),	 55.9	
(2OCH3),	 114.8	 (3C),	 126.4,	 128.0,	 129.4	 (3C),	 129.5	 (3C),	
131.3,	131.5,	132.1,	137.2,	154.1	(2C),	154.3,	154.5,	160.1	(3C),	
183.5	 (C=S),	 183.7	 (C=S).	 Anal.	 calcd.	 for	 C27H22N6O4S2:	 C,	
58.05;	H,	3.97;	N,	15.04.	Found:	C,	57.89;	H,	4.04;	N,	14.89%.	
3,3'‐(4‐Methyl‐1,3‐phenylene)bis(1‐(3‐ethoxyphenyl)‐4‐imi	
no‐5‐thioxoimidazolidin‐2‐one)	 (5d):	 Color:	Gray.	 Yield:	 80	%.	
M.p.:	148‐150	°C.	IR	(KBr,	ν,	cm‐1):	3343	(br,	2NH),	2977	(CH‐
aliph),	1779	(br,	2C=O),	1665	(br,	2C=NH).	1H	NMR	(300	MHz,	
DMSO‐d6,	 δ,	 ppm):	 1.36	 (t,	 6H,	 J	 =	 6.9	 Hz,	 CH3),	 2.27	 (s,	 3H,	
CH3),	4.04‐4.06	(q,	4H,	J	=	7.1	Hz,	CH2),	7.07‐7.79	(m,	11H,	Ar‐
H),	9.70	(s,	1H,	NH;	exchangeable	with	D2O),	9.74	(s,	1H,	NH;	
exchangeable	with	D2O).	13C	NMR	(75	MHz,	DMSO‐d6,	δ,	ppm):	
15.0	(2CH3),	17.9	(CH3),	65.4	(2CH2),	114.5	(3C),	115.9,	120.2	
(3C),	126.4,	128.0,	130.4	(3C),	131.5,	132.1,	134.9,	154.0,	154.1	
(2C),	 154.3,	 159.3	 (3C),	 183.3	 (2C=S).	 Anal.	 calcd.	 for	
C29H26N6O4S2:	 C,	 59.37;	H,	 4.47;	N,	 14.32.	 Found:	 C,	 59.23;	H,	
4.31;	N,	14.19%.	
	
2.2.	Antimicrobial	activity	
	
Chemical	 compounds	 were	 individually	 tested	 against	 a	
panel	of	Gram	positive	and	Gram	negative	bacterial	pathogens	
and	 fungi.	 Antimicrobial	 tests	 were	 carried	 out	 by	 the	 agar	
well	diffusion	method	using	100	μL	of	 suspension	containing	
1×108	 CFU/mL	 of	 pathological	 tested	 bacteria	 and	 1×106	
CFU/mL	 of	 fungi	 spread	 on	 nutrient	 agar	 and	 Sabouraud	
dextrose	agar	media,	respectively.	After	the	media	had	cooled	
and	 solidified,	wells	 (10	mm	 in	 diameter)	were	made	 in	 the	
solidified	 agar	 and	 loaded	 with	 100	 μL	 of	 tested	 compound	
solution	 prepared	 by	 dissolving	 5	 mg	 of	 the	 chemical	
compound	 in	 one	 mL	 of	 dimethyl	 sulfoxide	 (DMSO).	 The	
inoculated	 plates	 were	 then	 incubated	 for	 24	 h	 at	 37	 °C	 for	
bacteria,	 and	72	 h	 at	 28	 °C	 for	 fungi.	Negative	 controls	were	
prepared	 using	 DMSO	 employed	 for	 dissolving	 the	 tested	
compound.	 Ampicillin,	 gentamycin	 and	 amphotericin	 B	 (1	
mg/mL)	 were	 used	 as	 standard	 for	 antibacterial	 and	
antifungal	 activity,	 respectively.	 After	 incubation	 time,	
antimicrobial	activity	was	evaluated	by	measuring	the	zone	of	
inhibition	against	 the	 test	organisms	and	compared	with	 that	
of	 the	 standard.	 Antimicrobial	 activities	 were	 expressed	 as	
inhibition	 diameter	 zones	 in	 millimeters	 (mm).	 The	
experiment	was	carried	out	in	triplicate	and	the	average	zone	
of	inhibition	was	calculated.	
	
2.2.1.	Minimal	inhibitory	concentration	(MIC)	measurement	
	
The	 microdilution	 susceptibility	 test	 in	 Müller‐Hinton	
Broth	 (Oxoid)	 and	 Sabouraud	 Liquid	 Medium	 (Oxoid)	 was	
used	 for	 the	 determination	 of	 antibacterial	 and	 antifungal	
activity,	respectively.	Stock	solutions	of	the	tested	compounds,	
ampicillin,	gentamycin,	amphotericin	B	and	sulfisoxazole	were	
prepared	 in	 DMF	 at	 concentrations	 1000	 µg/mL.	 Each	 stock	
solution	 was	 diluted	 with	 standard	 method	 broth	 (Difco)	 to	
prepare	 serial	 twofold	 dilutions	 in	 the	 range	 of	 500‐0.007	
µg/mL.	 10	mL	 of	 the	 broth	 containing	 about	 106	 CFU/mL	 of	
test	 bacteria	 or	 104	 CFU/mL	of	 the	 test	 fungus	was	 added	 to	
each	well	 of	 96‐well	microtiter	 plate.	 The	 sealed	microplates	
were	incubated	at	37	°C	for	24	h	for	antibacterial	activity	and	
at	25	°C	for	48	h	for	antifungal	activity	in	a	humid	chamber.	At	
the	 end	 of	 the	 incubation	 period,	 the	 minimal	 inhibitory	
concentrations	 (MIC)	 values	 were	 recorded	 as	 the	 lowest	
concentrations	of	 the	 substance	 that	had	no	visible	 turbidity.	
Control	experiments	with	DMF	and	uninoculated	media	were	
run	parallel	to	the	test	compounds	under	the	same	conditions.	
	
3.	Results	and	discussion	
	
3.1.	Chemistry	
	
N‐arylcyanothioformamide	derivative	1a‐d	were	prepared	
by	 treating	 arylisothiocyanate	 with	 potassium	 cyanide	
according	 to	 literature	 procedures	 [10,14].	 Reaction	 of	N‐(4‐
florophenyl)cyanothioformamide	 derivative	 (1a)	 with	 aryl	
hydrazonomalononitrile	derivatives	in	ethanol	in	the	presence	
of	 triethylamine	as	a	 catalyst	under	 reflux	condition	afforded	
imidazolidineiminothione	 derivatives	 (2a‐c)	 containing	
arylazo	moiety	in	good	yields	(Scheme	1).	The	structure	of	the	
synthesized	 compounds	 was	 corroborated	 on	 the	 basis	 of	
spectral	 and	 analytical	 results.	 Infrared	 spectra	 of	 these	
compounds	 revealed	 absorption	 bands	 corresponding	 to	 NH,	
C≡N,	C=N	and	C=S	 functional	groups.	The	 1H	NMR	spectra	of	
compounds	2a‐c	 exhibited	 two	 singlet	 signals	 around	 δ	 8.60	
(C=NH)	and	9.60	ppm	(NH	imidazole	ring)	along	with	aromatic	
protons.	13C	NMR	spectra	of	compounds	2b,c	displayed	signals	
at	δ	187.8‐188.2	ppm	due	to	C=S.	The	reaction	mechanism	was	
assumed	 to	 proceed	 through	 a	 nucleophilic	 attack	 of	 the	
nitrogen	atom	of	 the	cyanothioformamide	moiety	 (1a)	 to	 the	
cyano	 group	 in	 arylhydrazonomalononitrile	 to	 form	 inter‐
mediate	 that	 followed	 by	 intramolecular	 cyclization	 to	 yield	
the	cyclized	products	2	as	illustrated	in	Scheme	1.	
Treating	 an	 ethereal	 solution	 of	 various	 N‐arylcyano	
thioformamides	 (1a,b,d)	with	 an	 equimolar	 amount	 of	 butyl	
isocyanate,	 followed	 by	 addition	 of	 a	 few	 drops	 of	
triethylamine	 as	 catalyst	 afforded	 imidazolidineiminothione	
derivatives	 (3a‐c)	 (Scheme	 2).	 The	 structure	 of	 compound	3	
has	 been	 assigned	 as	 a	 reaction	 product	 on	 the	 basis	 of	
analytical	and	spectral	data.	The	IR	spectra	of	compounds	3a‐c	
displayed	absorption	bands	around	3250	cm‐1	due	 to	NH	and	
1765	 cm‐1	 due	 to	 C=O	 function.	 The	 1H	 NMR	 spectra	 of	
compounds	 3a‐c	 exhibited	 triplet,	 sextet,	 quintet	 and	 triplet	
signals	 around	 δ	 0.91,	 1.33,	 1.67	 and	 3.68	 ppm,	 specific	 for	
butyl	 protons,	 respectively.	 Also,	 1H	 NMR	 spectra	 showed	
another	 specific	 broad	 signal	 around	 δ	 9.42	 ppm	 for	 NH	
proton.	 13C	 NMR	 spectrum	 of	 compound	 3b	 displayed	 four	
signals	 at	 δ	 13.5,	 19.3,	 20.8	 and	 29.0	 ppm	 for	 butyl	 carbons,	
three	 signals	 at	 δ	 153.8,	 154.6	 and	 183.1	 ppm	 for	 C=N,	 C=O	
and	 C=S,	 respectively.	 5‐Imino‐5‐thioxo‐2‐imidazolidinone	
derivatives	 (3a‐c)	 were	 furnished	 as	 the	 sole	 products,	
indicating	 that	 the	 ring	closing	 reaction	proceeds	via	 a	 single	
path,	 which	 involves	 attack	 via	 the	 nitrogen	 atom.	 The	
behavior	of	the	cyanothioformanilides	towards	2,4‐diisocyana	
totoluene	 was	 discussed.	 Thus,	 equimolar	 reaction	 between	
cyanothioformanilides	 (1b‐e)	and	2,4‐diisocyanato‐toluene	 in	
ether	 and	 in	 the	 presence	 of	 triethylamine	 caused	 cyclo‐
addition	reaction	to	furnish	5‐thioxoimidazo‐lidin‐2‐ones	(4a‐
d).	 On	 the	 other	 hand,	 bis‐imidazolidineiminothiones	 (5a‐d)	
were	 obtained	 via	 the	 reaction	 of	 cyanothioformanilide	 (1)	
with	 2,4‐diisocyanato‐toluene	 (2:1	 molar	 ratio)	 under	 the	
same	 reaction	 condition	 (Scheme	 2).	 The	 structures	 of	
compounds	4	and	5	have	been	assigned	as	a	reaction	product	
on	 the	 basis	 of	 analytical	 and	 spectral	 data.	 IR	 spectra	 of	
compound	 4	 showed	 signal	 around	 2270	 cm‐1	 due	 to	 the	
presence	of	isocyanate	group	while	IR	spectra	of	compound	5	
showed	 the	 complete	 disappearance	 of	 this	 signal.	Moreover	
IR	spectra	of	compounds	4	and	5	showed	the	presence	of	three	
signals	around	3340,	1779	and	1665	cm‐1	due	to	the	presence	
of	three	groups	NH,	C=O	and	C=N,	respectively.		
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Table	1.	Antimicrobial	activity	of	the	synthesized	compounds	against	the	pathological	organisms	expressed	as	inhibition	diameter	zones	in	millimeters	(mm)	
based	on	well	diffusion	assay.	
Compound	 Gram	positive	bacteria	 Gram	negative	bacteria Fungi
S.		
aureus	
S.		
epidermidis	
B.		
subtilis	
N.		
gonorrhoeae	
E.		
coli	
K.		
pneumoniae	
A.		
fumigatus	
A.		
clavatus	
G.		
candidum	
2a	 17.8±0.48	 14.9±0.23	 17.2±0.48 16.9±0.41 17.5±0.43 14.6±0.53 17.6±0.35	 12.7±0.43	 11.7±0.43
2b	 0	 0	 0	 0	 0	 0	 0	 0	 0	
2c	 0	 0	 0	 0	 0	 0	 0	 0	 0	
3a	 28.2±0.54	 25.4±0.47	 28.6±0.51	 19.8±0.63	 20.1±0.48	 24.5±0.58	 19.0±0.12	 17.3±0.26	 19.8±0.26	
3b	 11.5±0.43	 10.3±0.23	 16.5±.042 12.3±0.43 10.6±0.26 9.5±0.34 23.3±0.54	 22.6±0.57	 26.9±0.38
4a	 20.9±0.44	 19.7±0.59	 21.8±0.47 17.3±0.32 18.8±0.54 16.47±0.54 16.6±0.34	 15.6±0.43	 13.9±0.32
4b	 15.9±0.45	 14.8±0.24	 17.2±0.64 13.2±0.36 15.3±0.35 17.4±0.38 15.7±0.36	 14.6±0.43	 12.8±0.38
4c	 10.2±0.42	 9.3±0.50	 12.2±0.63 0 0 0 9.6±0.23 9.8±0.46	 11.5±0.27
5a	 22.7±0.65	 20.8±0.45	 22.7±0.56 21.4±0.41 22.5±	0.36 21.4±0.36 18.7±0.28	 20.93±0.38	 24.8±0.54
5b	 0	 0	 12.23±0.2 0 0 0 0 10.9±0.34	 9.8±0.27
5c	 19.9±0.64	 20.8±0.32	 21.7±0.37 20.9±0.45 20.9±0.36 22.1±0.53 19.7±0.28	 21.8±0.27	 22.7±0.39
Ampicillin	 28.9±0.14	 25.4±0.18	 29.8±0.35 ‐ ‐ ‐ ‐ ‐	 ‐	
Gentamycin	 ‐	 ‐	 ‐	 22.3±0.58 23.4±0.3 26.3±0.15 ‐ ‐	 ‐	
Amphotericin	B	 ‐	 ‐	 ‐	 ‐ ‐ ‐ 23.7±0.10	 21.9±0.12	 25.4±0.16
	
	
The	 1H	 NMR	 spectra	 of	 compounds	 4	 and	 5	 displayed	
characteristic	signals	due	aliphatic	protons	and	broad	signals	
assignable	the	NH.	The	13C	NMR	spectra	of	compounds	4	and	5	
displayed	 characteristic	 signals	 for	 the	 carbon	 of	 CH3,	 OCH3,	
C=NH,	C=O	and	C=S	groups.	
	
3.2.	Antimicrobial	activity	
	
The	search	for	newer	antibacterial	and	antifungal	agents	is	
still	 in	 continuation;	 due	 to	 the	 rapid	 development	 of	 the	
resistance	 among	 bacteria	 and	 fungi.	 Imidazolidineimino	
thione	derivatives	may	comprise	a	new	class	of	antimicrobial	
agents	with	 diminished	 resistance.	 Therefore,	 the	 aim	 of	 the	
present	 investigation	 is	 to	 synthesize	 different	 series	 of	
imidazolidineiminothione	 derivatives	 which	 bearing	 various	
substituent	 at	C2,	N1	 and	N3.	 Accordingly,	 these	 compounds	
were	 synthesized	 and	 tested	 for	 their	 expected	 effect(s)	
against	 selected	 Gram‐positive,	 Gram‐negative	 bacteria	 and	
fungi	species.	
	
3.2.1.	Antibacterial	and	antifungal	activities	
	
The	 synthesized	 compounds	 were	 tested	 in	 vitro	 for	
antibacterial	 and	 antifungal	 activities	 against	 the	 following	
strains:	 three	 Gram‐positive	 bacteria,	 Staphylococcus	 aureus	
(RCMB	 010027),	 Staphylococcus	 epidermidis	 (RCMB	 010024)	
and	 Bacillus	 subtilis	 (RCMB	 010063);	 three	 Gram‐negative	
bacteria,	 Neisseria	 gonorrhoeae	 (RCMB	 010079),	 Escherichia	
coli	 (RCMB	 010052)	 and	 Klebsiella	 pneumoniae	 (RCMB	
010093)	 and	 three	 Fungi,	 Aspergillus	 fumigatus	 (RCMB	
02564),	 Aspergillus	 clavatus	 (RCMB	 02593)	 and	 Geotrichum	
candidum	(RCMB	05096),	and	the	results	were	summarized	in	
Table	 1.	 The	 synthesized	 compounds	 were	 tested	 for	 anti‐
microbial	activity	by	the	agar	diffusion	method	[20]	using	a	1	
cm	 microplate	 well	 diameter	 and	 a	 100	 μL	 of	 each	
concentration.	Antimicrobial	tests	were	carried	out	using	100	
μL	of	 tested	compound	solution	prepared	by	dissolving	5	mg	
of	 the	 chemical	 compound	 in	 1	 mL	 of	 dimethyl	 sulfoxide	
(DMSO).	 Ampicillin,	 gentamycin	 and	 amphotericin	 B	 (1	
mg/mL)	were	used	 as	 standard	 references	 for	Gram	positive	
bacteria,	 Gram	 negative	 bacteria	 and	 antifungal	 activity,	
respectively.	Certain	aspects	of	the	structure	activity	relation‐
ships	of	the	prepared	compounds	were	clearly	highlighted.	
The	 results	 of	 the	 antimicrobial	 screening	 demonstrated	
the	 following	 assumptions	 about	 the	 structural	 activity	
relationship	 (SAR).	 Incorporating	 arylazo	 moiety	 as	 in	
structure	2	had	a	detrimental	effect	on	antimicrobial	activity.	
Structure	2	has	 at	C2	 side	 chain	 ending	with	 arylazo	moiety	
(Aryl:	 2a;	 3,4‐dichlorophenyl,	 2b;	 4‐methylphenyl,	 2c;	 4‐
methoxyphenyl).	 The	 presence	 of	 3,4‐dichlorophenyl	 moiety	
(2a)	 resulted	 in	 the	 highest	 antimicrobial	 activity	 among	 all	
the	compounds	investigated	in	this	structure.	The	presence	of	
3,4‐dichlorophenyl	moiety	exhibited	moderate	activity	against	
most	 of	 the	 tested	 organisms.	 4‐Methylphenyl	 (2b)	 and	 4‐
methoxyphenyl	 (2c)	 showed	 no	 activity	 against	 all	 tested	
organisms.	 Imidazolidineiminothione	 derivatives	 (3a‐c)	
contain	4‐fluorophenyl	(3a),	4‐methylphenyl	(3b),	4‐methoxy	
phenyl	(3c)	moieties	at	N3	and	butyl	moiety	at	N1:	Regarding	
the	 effect	 of	 the	 aryl	 substitution	 at	 N3,	 the	 type	 of	 the	
substitutions	on	the	benzene	ring	of	aryl	moiety	is	 important.	
It	 was	 noticed	 that	 the	 presence	 of	 4‐fluorophenyl	 in	
compound	 3a	 showed	 the	 maximum	 activities	 against	 most	
the	 test	 bacterial	 strains	 which	 showed	 near	 the	 reference	
drug.	 On	 the	 other	 hand,	 compound	3a	 showed	moderate	 to	
good	activity	against	the	tested	fungi	strains.	Unlike	compound	
3a,	 4‐methylphenyl	 (3b)	 and	4‐methoxyphenyl	 (3c)	moieties	
showed	 moderate	 activities	 against	 most	 the	 test	 bacterial	
strains	and	showed	high	activity	against	the	tested	fungi	near	
the	reference	drug.	Imidazolidineiminothione	derivatives	(4a‐
d)	 contains	 4‐methylphenyl	 (4a),	 3‐methoxylphenyl	 (4b),	 4‐
methoxyphenyl	(4c),	3‐ethoxylphenyl	(4d)	moieties	at	N1	and	
3‐isocyanato‐4‐methylphenyl	 moiety	 at	 N3.	 Regarding	 the	
effect	 of	 the	 aryl	 substitution	 at	N1,	 it	 was	 noticed	 that	 the	
presence	of	methylphenyl	moiety	(4a)	resulted	in	the	highest	
antimicrobial	activity	among	all	the	compounds	investigated	in	
this	structure.	The	presence	of	methylphenyl	moiety	exhibited	
moderate	to	good	activity	against	most	of	the	tested	organisms	
while	 4‐methoxyphenyl	 (4c)	 showed	 weak	 to	 moderate	
activity	 against	 all	 tested	 organisms.	 Bis‐imidazolidineimino	
thione	 derivatives	 (5a‐d)	 contains	 4‐methyl‐phenyl	 (5a),	 3‐
methoxyphenyl	 (5b),	 4‐methoxyphenyl	 (5c),	 3‐ethoxylphenyl	
(5b),	 moieties	 at	 N1	 and	 methylphenylene	 linker	 at	 N3.	
Regarding	 the	 effect	 of	 the	 aryl	 substitution	 at	 N1,	 It	 was	
noticed	 that	 the	 presence	 of	 para	 substitution	 at	 phenyl	
moiety	resulted	in	the	highest	antimicrobial	activity	among	all	
the	 compounds	 investigated	 in	 this	 structure.	Bis‐compounds	
5a,c	 with	 two	 imidazolidineiminothione	 moiety	 showed	
activity	 in	 some	 cases	 equipotent	 to	 the	 reference	 drug;	
especially	against	fungi.		
	
3.2.1.1.	MIC	of	the	most	active	compounds	
	
Minimum	 inhibitory	 concentration	 (MIC)	 of	 the	 most	
active	synthesized	compounds	3a,	5a	and	5c	was	evaluated	in	
vitro	using	the	related	reference	[21].	The	results	of	minimum	
inhibitory	concentration	were	depicted	 in	Table	2.	Regarding	
the	 effect	 of	 each	 substituent	 at	 C2	 and	 those	 at	N1	 and	N3	
against	 bacterial	 and	 fungal	 strains,	 results	 of	 antimicrobial	
activity	 in	 this	 study	 revealed	 that:	 Compound	 3a	 showed	
about	 25%	 less	 potent	 effect	 than	 Ampicillin	 against	 S.	
epidermidis	 and	 B.	 subtilis	 (MIC,	 0.49	 μg/mL)	 and	 showed	
about	 50%	 less	 potent	 effect	 than	Amphotericin	 B	 against	A.	
clavatus	and	G.	Candidum.		
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Table	2.	Minimum	inhibitory	concentration	(µg/mL)	of	the	more	potent	synthesized	compounds	against	the	pathological	organisms.	
Compound	 Gram	positive	bacteria	 Gram	negative	bacteria	 Fungi	
S.		
aureus	
S.	
epidermidis	
	B.		
subtilis	
N.	
gonorrhoeae	
E.	
coli	
K.	
pneumoniae	
A.	
fumigatus	
A.		
clavatus	
G.	
candidum	
2a	 0.98	 0.49	 0.49	 15.63 7.81 15.63 1.95 0.98	 0.24
5a	 0.49	 1.95	 1.95	 0.49 3.9 15.63 0.98 0.98	 1.95
5c	 1.95	 1.95	 0,98	 1.95 0.49 1.95 0.98 7.81	 1.95
Ampicillin	 0.03	 0.12	 0.15	 ‐	 ‐	 ‐	 ‐	 ‐	 ‐	
Gentamycin	 ‐	 ‐	 ‐	 0.49 0.24 0.12 ‐ ‐	 ‐	
Amphotericin	B	 ‐	 ‐	 ‐	 ‐ ‐ ‐ 0.12 0.49	 0.12
	
	
Compound	 5a	 was	 equipotent	 to	 the	 Gentamycin	 in	
inhibiting	 the	 growth	 of	N.	 gonorrhoeae	 (MIC,	 0.49	 μg/mL),	
and	displayed	50%	less	activity	compared	 to	Amphotericin	B	
against	 A.	 clavatus.	 Compound	 5c	 showed	 about	 50%	 less	
potent	 effect	 than	 Gentamycin	 against	 E.	 coli	 (MIC,	 0.49	
µg/mL).	
	
4.	Conclusion		
	
The	objective	of	 the	present	 study	was	 to	 synthesize	 and	
investigate	 the	 antimicrobial	 activities	 of	 some	new	 imidazo‐
lidineiminothione	which	bearing	various	substituent	at	N1	and	
others	at	N3	beside	various	substituent	at	C2	with	the	hope	of	
discovering	new	 structure	 leads	 serving	 as	potent	 antimicro‐
bial	 agents.	 Our	 aim	 has	 been	 verified	 by	 the	 synthesis	 of	
imidazolidineiminothione,	 imidazolidineimino	 thione	contain‐
ing	 arylazo	moiety	 and	bis‐imidazolidine‐iminothione	 deriva‐
tives.	 It	 is	worth	mentioning	 that,	 imidazole	 dineiminothione	
derivative	3a	contain	4‐fluorophenyl	at	N3	and	butyl	moiety	at	
N1	 showed	 the	 maximum	 activities	 against	 most	 the	 test	
bacterial	 strains	which	 showed	 near	 the	 reference	 drug.	Bis‐
imidazolidineiminothione	 5a	 was	 equipotent	 to	 the	
Gentamycin	 in	 inhibiting	 the	 growth	 of	N.	gonorrhoeae	 (MIC,	
0.49	 μg/mL),	 and	 displayed	 50%	 less	 activity	 compared	 to	
Amphotericin	 B	 against	 A.	 clavatus.	While,	 bis‐imidazolidine	
iminothione	 5c	 showed	 about	 50%	 less	 potent	 effect	 than	
Gentamycin	against	E.	coli	(MIC,	0.49	µg/mL).	
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